Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
EBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxRevenueShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Cellectis (CLLS) EPS (Weighted Average and Diluted) (2023)

Cellectis has reported EPS (Weighted Average and Diluted) over the past 1 years, most recently at -$0.68 for Q4 2023.

  • Quarterly results put EPS (Weighted Average and Diluted) at -$0.68 for Q4 2023, changed N/A from a year ago — trailing twelve months through Dec 2025 was -$0.59 (up 24.22% YoY), and the annual figure for FY2025 was -$0.67, down 63.41%.
  • EPS (Weighted Average and Diluted) for Q4 2023 was -$0.68 at Cellectis, down from -$0.2 in the prior quarter.
  • Over the last five years, EPS (Weighted Average and Diluted) for CLLS hit a ceiling of -$0.2 in Q2 2023 and a floor of -$0.68 in Q4 2023.